Summary & Overview

HIV with Extensive O.R. Procedures without MCC: Inpatient Reimbursement Overview

DRG 970 encompasses inpatient stays for human immunodeficiency virus infection requiring extensive operating room procedures without a Major Complication or Comorbidity; it defines a surgical-heavy case mix within HIV care. Understanding this Diagnosis-Related Group is important for inpatient reimbursement because it determines bundled Medicare payment levels based on the intensity of operative services and coded comorbidities.

HIV with Extensive O.R. Procedures without MCCDRG HIV with Extensive O.R. Procedures without MCCDRG 970Diagnosis-Related GroupInpatient ReimbursementMedicareInfectious Disease SurgerySurgical Resource UseHospital CodingPayment Classification

DRG 970 Overview

DRG 970 covers hospital inpatient stays for patients with human immunodeficiency virus infection who undergo extensive operating room procedures without a Major Complication or Comorbidity. This Diagnosis-Related Group captures cases with significant surgical resource use in the setting of human immunodeficiency virus care but without higher-severity comorbid conditions. It matters for Medicare payment because it groups similar clinical and resource profiles to determine bundled reimbursement for the inpatient episode. Accurate coding of procedures and comorbidities directly affects payment classification within this Diagnosis-Related Group.

Clinical Trials

Acute perioperative management studies focused on optimizing surgical outcomes for people with advanced HIV undergoing extensive operating room procedures. These studies enroll hospitalized adult patients with HIV who require major operations (e.g., abdominal, thoracic, or multi-cavity procedures) to evaluate strategies such as antimicrobial prophylaxis timing, perioperative immune and viral load monitoring, and protocols for antiretroviral therapy (ART) interruption versus continuation. Findings are directly relevant to inpatient providers for reducing surgical complications and to payers for understanding drivers of length of stay and high-cost resource use associated with complex operative courses.
Comparative effectiveness trials assessing different intraoperative and immediate postoperative approaches to reduce complications and rehospitalization in immunocompromised surgical patients. Trials may compare enhanced infection prevention bundles, transfusion thresholds, or intensified wound care regimens in cohorts of people with HIV with varying CD4 counts or comorbidities (e.g., hepatitis coinfection, substance use). Results inform clinical pathways and bundled payment models by identifying which perioperative strategies lower complication rates, ICU days, and downstream costs in this high-risk DRG group.
Post-discharge outcomes and care-transition research examining rehabilitation needs, adherence to antiretroviral therapy, and long-term functional recovery after extensive surgery in people living with HIV. These observational or interventional studies follow patients after discharge to measure readmissions, wound complication rates, ART continuity, and quality-of-life metrics, often stratified by baseline immunologic status and social determinants of health. Such evidence guides discharge planning, outpatient resource allocation, and payer decisions about coverage for home health, rehabilitation, and case management to reduce readmissions and total cost of care.

Clinical Trials

Acute perioperative management studies focused on optimizing surgical outcomes for people with advanced HIV undergoing extensive operating room procedures. These studies enroll hospitalized adult patients with HIV who require major operations (e.g., abdominal, thoracic, or multi-cavity procedures) to evaluate strategies such as antimicrobial prophylaxis timing, perioperative immune and viral load monitoring, and protocols for antiretroviral therapy (ART) interruption versus continuation. Findings are directly relevant to inpatient providers for reducing surgical complications and to payers for understanding drivers of length of stay and high-cost resource use associated with complex operative courses.
Comparative effectiveness trials assessing different intraoperative and immediate postoperative approaches to reduce complications and rehospitalization in immunocompromised surgical patients. Trials may compare enhanced infection prevention bundles, transfusion thresholds, or intensified wound care regimens in cohorts of people with HIV with varying CD4 counts or comorbidities (e.g., hepatitis coinfection, substance use). Results inform clinical pathways and bundled payment models by identifying which perioperative strategies lower complication rates, ICU days, and downstream costs in this high-risk DRG group.
Post-discharge outcomes and care-transition research examining rehabilitation needs, adherence to antiretroviral therapy, and long-term functional recovery after extensive surgery in people living with HIV. These observational or interventional studies follow patients after discharge to measure readmissions, wound complication rates, ART continuity, and quality-of-life metrics, often stratified by baseline immunologic status and social determinants of health. Such evidence guides discharge planning, outpatient resource allocation, and payer decisions about coverage for home health, rehabilitation, and case management to reduce readmissions and total cost of care.

OpenPayer

Summary & Overview

HIV with Extensive O.R. Procedures without MCC: Inpatient Reimbursement Overview

DRG 970 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes